;11(10) Wang Y, Wan R, Hu C (2023) Leptin/obR signaling exacerbates obesity-related neutrophilic airway inflammation through inflammatory M1 macrophages
This results in enhanced insulin response and reduced glucagon levels, outperforming the impact of either GIP or GLP-1 therapies when used independently
Yes, when they're prescribed by a licensed provider and sourced through a regulated supply chain
Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2.4 mg for weight management: a randomised, controlled, phase 1b trial Summary: This Phase 1b trial assessed the safety, tolerability, pharmacokinetics, and pharmacodynamics of co-administering once-weekly subcutaneous cagrilintide (at various doses) with semaglutide 2.4 mg in participants for weight management
Some researchers prefer this because the slightly lower concentration gives them more precision, especially if they are doing half-step escalations like 6mg or 10mg between the standard protocol doses